DK0520406T3 - Diastereomert salt af optisk aktiv quinolinmevalonsyre - Google Patents

Diastereomert salt af optisk aktiv quinolinmevalonsyre

Info

Publication number
DK0520406T3
DK0520406T3 DK92110636T DK92110636T DK0520406T3 DK 0520406 T3 DK0520406 T3 DK 0520406T3 DK 92110636 T DK92110636 T DK 92110636T DK 92110636 T DK92110636 T DK 92110636T DK 0520406 T3 DK0520406 T3 DK 0520406T3
Authority
DK
Denmark
Prior art keywords
optically active
diastereomeric salt
mevalonic acid
active quinoline
quinoline
Prior art date
Application number
DK92110636T
Other languages
Danish (da)
English (en)
Inventor
Yoshio Ohara
Mikio Suzuki
Yoshinobu Yanagawa
Hiroshi Iwasaki
Nobuhide Miyachi
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Application granted granted Critical
Publication of DK0520406T3 publication Critical patent/DK0520406T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK92110636T 1991-06-24 1992-06-24 Diastereomert salt af optisk aktiv quinolinmevalonsyre DK0520406T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15181091 1991-06-24
JP12727792A JP3528186B2 (ja) 1991-06-24 1992-05-20 光学活性キノリンメバロン酸のジアステレオマー塩

Publications (1)

Publication Number Publication Date
DK0520406T3 true DK0520406T3 (da) 1998-12-14

Family

ID=26463266

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92110636T DK0520406T3 (da) 1991-06-24 1992-06-24 Diastereomert salt af optisk aktiv quinolinmevalonsyre

Country Status (10)

Country Link
US (3) US5284953A (fr)
EP (2) EP0742209A3 (fr)
JP (1) JP3528186B2 (fr)
KR (1) KR100208867B1 (fr)
AT (1) ATE170513T1 (fr)
CA (1) CA2072162C (fr)
DE (1) DE69226822T2 (fr)
DK (1) DK0520406T3 (fr)
ES (1) ES2120973T3 (fr)
TW (1) TW293007B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3776452B2 (ja) * 1994-02-25 2006-05-17 ダイセル化学工業株式会社 光学活性なメバロノラクトン系化合物の製造方法
IL128862A (en) 1995-07-17 2007-12-03 Warner Lambert Co [R - (R * R *)] - 2 - (4 - fluorophenyl) - ß, d - dihydroxy - 5 - (1 - methyl - ethyl) 3 - phenyl - 4 - [(phenamino) carbonyl)] - 1H - Pyrol - 1 - Patenoic acid Hydrogen salt Hydrogen crystalline (Atorostatin) Crystalline hydrate
DE69625046T2 (de) * 1995-12-22 2003-04-10 Kowa Co., Ltd. Pharmazeutische zusammensetzung stabilisiert mit einem basischen medium
GB9614804D0 (en) * 1996-07-15 1996-09-04 Chiroscience Ltd Resolution process
NZ504346A (en) * 1997-12-19 2001-11-30 Warner Lambert Exp Ltd Process for the synthesis of 1,3-diols characterised by either reconcentration step with either trialkylborane or dialkylalkoxyborane or a mixture of both trialkylborane and dialkylalkoxyborane
RU2214402C2 (ru) 1998-07-23 2003-10-20 Ниссан Кемикал Индастриз, Лтд. Способ получения 3-((2-циклопропил-4-(4-фторфенил)-3-хинолил)проп-2-еналя и промежуточное соединение
KR100311645B1 (ko) * 1999-12-24 2001-10-12 이홍천 간판
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
KR100838135B1 (ko) * 2001-04-05 2008-06-13 닛산 가가쿠 고교 가부시키 가이샤 7-퀴놀리닐-3,5-디히드록시헵트-6-엔산에스테르의 제조법
JP4783998B2 (ja) * 2001-05-15 2011-09-28 宇部興産株式会社 (3r,5s)−7−置換−3,5−ジヒドロキシヘプト−6−エン酸の製法
WO2003027073A1 (fr) * 2001-09-19 2003-04-03 Ube Industries, Ltd. Procede de production d'ester optiquement actif d'acide 7-{2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl}-3,5-dihydroxyhept-6-enoique
US6835838B2 (en) * 2002-01-28 2004-12-28 Novartis Ag Process for the manufacture of organic compounds
JP4524111B2 (ja) 2002-01-31 2010-08-11 ノバルティス アーゲー HMG−CoA還元酵素阻害剤の製造法
KR101067314B1 (ko) 2002-09-20 2011-09-23 닛산 가가쿠 고교 가부시키 가이샤 3,5-디하이드록시-6-헵테노에이트 제조 방법
WO2004072040A1 (fr) * 2003-02-12 2004-08-26 Ciba Specialty Chemicals Holding Inc. Formes cristallines de calcium de pitavastatine
EP1614429A4 (fr) * 2003-04-17 2007-05-02 Kowa Co Promoteur de l'expression du gene lklf/klf2
WO2005053683A1 (fr) * 2003-11-26 2005-06-16 Duke University Technique de prevention ou de traitement du glaucome
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
EP1709008A1 (fr) * 2004-01-19 2006-10-11 Ranbaxy Laboratories Limited Sels des inhibiteurs de hmg-coa reductase et leur utilisation
CN101220021B (zh) * 2007-01-12 2010-12-08 上海医药工业研究院 4-取代苯氧基喹啉类化合物及其中间体、制备方法和应用
WO2008111055A1 (fr) * 2007-03-12 2008-09-18 In-Dot Ltd. Détection de couleur pour un dispositif de lecture et similaire
WO2010027060A1 (fr) * 2008-09-05 2010-03-11 日産化学工業株式会社 Procédé pour la fabrication de sel d'amine d'acide 3,5-dihydroxy-6-hepténoïque
WO2011089623A2 (fr) 2010-01-20 2011-07-28 Cadila Healthcare Limited Procédé pour la préparation de pitavastatine et de sels pharmaceutiquement acceptables de celle-ci
WO2012025939A1 (fr) 2010-08-25 2012-03-01 Cadila Healthcare Limited Calcium de pitavastatine et son procédé de préparation
EP3178812A1 (fr) * 2010-11-12 2017-06-14 Hetero Research Foundation Nouveaux polymorphes de calcium de pitavastatine
KR101270586B1 (ko) * 2010-11-26 2013-06-03 주식회사 아미노로직스 광학적으로 순수한 2,2'-디히드록시-1,1'-바이나프틸-3-카르복실산의 제조방법
WO2012140490A2 (fr) 2011-04-11 2012-10-18 Aurobindo Pharma Limited Procédé de préparation de dérivé de quinoléine
JP2011173912A (ja) * 2011-04-28 2011-09-08 Ube Industries Ltd (3r,5s)−7−置換−3,5−ジヒドロキシヘプト−6−エン酸の製法
EP2751081B1 (fr) 2011-09-12 2017-01-04 Farma GRS, d.o.o. Forme polymorphe de calcium de pitavastatine
JP2013103884A (ja) * 2011-11-10 2013-05-30 Daito Kk ピタバスタチンカルシウム塩の工業的製造方法
CN102653523A (zh) * 2011-12-17 2012-09-05 东莞达信生物技术有限公司 一种匹伐他汀钙重结晶制取方法
WO2013098773A1 (fr) * 2011-12-28 2013-07-04 Dr. Reddy's Laboratories Limited Formes cristallines de pitavastatine calcique
CN102653524A (zh) * 2012-01-12 2012-09-05 东莞达信生物技术有限公司 一种匹伐他汀钙中间体的制备方法
CN105189458A (zh) * 2013-03-29 2015-12-23 中化帝斯曼制药有限公司荷兰公司 匹伐他汀和罗素伐他汀的胺盐
MX2015013696A (es) * 2013-03-29 2016-02-26 Dsm Sinochem Pharm Nl Bv Sales de amina de pitavastatina y rosuvastatina.
CN103508949B (zh) * 2013-10-22 2015-12-09 黄河三角洲京博化工研究院有限公司 一种(e)-3-[2-环丙基-4-(4-氟-苯基)-3-喹啉基]丙烯醛的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH576447A5 (fr) * 1972-03-10 1976-06-15 Ciba Geigy Ag
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
CA1336714C (fr) * 1987-08-20 1995-08-15 Yoshihiro Fujikawa Mevalonolactone de type quinoleine utilisee comme inhibiteurs de la biosynthese du cholesterol
DE3905908A1 (de) * 1989-02-25 1990-09-06 Bayer Ag Substituierte chinoline, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
FI94339C (fi) * 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
DE3925636A1 (de) * 1989-08-03 1991-02-07 Bayer Ag Imino-substituierte pyridine
EP0430129A3 (en) * 1989-11-30 1992-02-26 Tanabe Seiyaku Co., Ltd. Novel phenylethylene derivatives, processes for preparing the same and intermediates therefor
JPH054943A (ja) * 1990-08-30 1993-01-14 Sagami Chem Res Center 光学活性β,δ−ジケト酸エステル及びその還元体

Also Published As

Publication number Publication date
EP0742209A2 (fr) 1996-11-13
KR930000486A (ko) 1993-01-15
US5284953A (en) 1994-02-08
ES2120973T3 (es) 1998-11-16
EP0520406B1 (fr) 1998-09-02
KR100208867B1 (ko) 1999-07-15
DE69226822D1 (de) 1998-10-08
CA2072162A1 (fr) 1992-12-25
ATE170513T1 (de) 1998-09-15
EP0520406A1 (fr) 1992-12-30
JP3528186B2 (ja) 2004-05-17
DE69226822T2 (de) 1999-02-11
CA2072162C (fr) 2002-11-19
EP0742209A3 (fr) 1997-05-14
US5514804A (en) 1996-05-07
JPH05148237A (ja) 1993-06-15
US5473075A (en) 1995-12-05
TW293007B (fr) 1996-12-11

Similar Documents

Publication Publication Date Title
DK0520406T3 (da) Diastereomert salt af optisk aktiv quinolinmevalonsyre
DE69327567D1 (de) Verfahren zur Herstellung von Alanylglutamin
ATE72224T1 (de) Verfahren zur optischen spaltung von 2-(6-methoxy-2-naphtyl)propionsaeure.
NO902839D0 (no) Fremgangsmaate for rensing av tryptofan.
DE69328962D1 (de) Verfahren zur herstellng von cyano-methoxyiminomethylderivaten
FI955498A0 (fi) Nipekotiinihappojohdannaisia hyytymistä estävinä aineina
UA8357A1 (uk) Спосіб оптичного поділу піранобензоксадіазольної сполуки
DE69018716D1 (de) Verfahren zur optischen Aufspaltung von pyranobenzoxadiazolverbindungen.
DE59302245D1 (de) Verfahren zur Herstellung von Distyrylbiphenylverbindungen
PT100159A (pt) Processo para a preparacao de trans-piperidino-2,5-dicarboxilatos
ATE321033T1 (de) Verfahren zur herstellung von substituierten alkylaminen oder salzen davon
ATE103276T1 (de) Verfahren zur herstellung von chinolin-2,3carbons|ure.
IT9022209A0 (it) Processo per la granulazione di sali potessici
IN170286B (fr)
BR9405262A (pt) Processo para a preparação de um ácido piridina-2,3-dicarboxílico
ES2195309T3 (es) Derivados de tetrahidrofurano.
ATE66459T1 (de) Herstellungsverfahren von trifluormethylverbindungen.
ES2164258T3 (es) Procedimiento de preparacion de derivados de carbamoilmetilurea.
FI93355B (fi) Menetelmä uuden, kouristusta laukaisevan, 2-/4-(2-piperidinoetoksi)bentsoyyli/bentsoehapon isopropyyliesterin valmistamiseksi
DK0837066T3 (da) Forbedret fremgangsmåde til fremstilling af penicillin G phenylester
FR2616147B1 (fr) Procede d'obtention de derives d'acides 4-phenoxyphenoxy-alcanecarboxyliques